Barbara Savoldo

Active 2001–2026

101
Papers
19,562
Citations
73
h-index
97
i10-index

Citations

Citations per year for Barbara Savoldo1999: 1 citations2002: 5 citations2003: 8 citations2004: 15 citations2005: 17 citations2006: 20 citations2007: 25 citations2008: 33 citations2009: 80 citations2010: 115 citations2011: 110 citations2012: 122 citations2013: 223 citations2014: 191 citations2015: 284 citations2016: 308 citations2017: 352 citations2018: 401 citations2019: 850 citations2020: 1,086 citations2021: 1,119 citations2022: 1,051 citations2023: 825 citations2024: 1,237 citations2025: 732 citations2026: 19 citations2000–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,627 citing papers, 33.8% of this breakdownChina: 1,214 citing papers, 15.6% of this breakdownGermany: 503 citing papers, 6.5% of this breakdownUnited Kingdom: 376 citing papers, 4.9% of this breakdownItaly: 339 citing papers, 4.4% of this breakdownFrance: 248 citing papers, 3.2% of this breakdownCanada: 172 citing papers, 2.2% of this breakdownAustralia: 167 citing papers, 2.2% of this breakdownJapan: 164 citing papers, 2.1% of this breakdownSpain: 157 citing papers, 2% of this breakdownSwitzerland: 149 citing papers, 1.9% of this breakdownNetherlands: 143 citing papers, 1.8% of this breakdown
0%33.8%Other 19.4%

Fields

  • Medicine78.9%
  • Biochemistry, Genetics and Molecular Biology9.4%
  • Immunology and Microbiology9.1%
  • Engineering1.1%
  • Neuroscience0.6%
  • Materials Science0.3%
  • Other0.6%

Topics

  • CAR-T cell therapy research23.9%
  • Immune Cell Function and Interaction8.8%
  • Virus-based gene therapy research8.1%
  • Immunotherapy and Immune Responses6.2%
  • Nanowire Synthesis and Applications5.2%
  • Viral Infectious Diseases and Gene Expression in Insects4%
  • Other43.8%

Coauthors

All papers

Open in search
  1. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

    Authors: , , , , , , , , , , , , - Blood 2014 cited by 736

  2. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,495

  3. Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

    Authors: , , , , , , , , - Blood Cancer Discovery 2021 cited by 295

  4. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

    Authors: , , , , , , , , , , , , , , , , , - Molecular Therapy 2017 cited by 530

  5. Immunogenicity of CAR T cells in cancer therapy

    Authors: , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 297

  6. Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

    Authors: , , , , , , , , , , , , , , , , - Blood 2011 cited by 1,171

  7. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    Authors: , , , , , , , , , , - Nature Cancer 2021 cited by 209

  8. Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 276

  9. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2008 cited by 1,190

  10. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 380

  11. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2018 cited by 293

  12. Interleukin-23 engineering improves CAR T cell function in solid tumors

    Authors: , , , , , , , , , , , , , , - Nature Biotechnology 2020 cited by 243

  13. Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15

    Authors: , , , , , - Clinical Cancer Research 2019 cited by 199

  14. A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 261

  15. NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 cited by 185

  16. Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

    Authors: , , , , , , , , , , , , - Nature Communications 2022 cited by 101

  17. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres

    Authors: , , , , , , , , , , , , , , , , - EBioMedicine 2019 cited by 183

  18. CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 1,013

  19. Design and development of therapies using chimeric antigen receptor‐expressing T cells

    Authors: , , , - Immunological Reviews 2013 cited by 507

  20. Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor–Modified T Cells in Solid Tumors

    Authors: , , , , , , , , - Cancer Research 2014 cited by 326

  21. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 506

  22. THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells

    Authors: , , , , , , , , , , , , , - Cancer Cell 2020 cited by 153

  23. GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision

    Authors: , , , , , , , - Nature Cancer 2020 cited by 123

  24. Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma

    Authors: , , , , , , , , , , , , - Science Advances 2021 cited by 83